AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Xbrane Biopharma

Declaration of Voting Results & Voting Rights Announcements Feb 15, 2024

3128_iss_2024-02-15_29199170-208d-48eb-a5ba-75d24918d2a6.pdf

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

Issuer Xbrane Biopharma AB

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument
------------
Aktier
Data not given*
Data not given*
Reason for major shareholding notification Buy
14/02/2024
5 %
5 %
1,332,839
0
1,332,839
4.47106 %
0 %
4.47106 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 4.47106 % 1,332,839
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled 0.63192 % 188,378
Total 5.10298 % 1,521,217

Group total holdings

Voting rights 1,521,217 Percentage of voting rights 5.10298

Notes (other relevant informations according to law)

Flaggning sker för passerat tröskelvärde beträffande det aggregerade innehavet. Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt förvärvat de aktuella värdepapperna.

Published

15/02/2024 14:58

Contact

Name Joakim Lomell

Email [email protected]

*Source of information has chosen not to submit the data

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.